MUMBAI (Reuters) – Indian drugmaker Wockhardt Ltd (WCKH.NS) said on Monday it has received approval from the U.S. Food and Drug Administration to sell Entacapone tablets, which are used in treatment of Parkinson’s disease.
Entacapone, which will be launched on September 30 with a 180-day exclusive period, is the generic name for the brand Comtan, owned by Orion Corp. (001800.KS), Wockhardt said in a statement on its website.
(Reporting by Siddesh Mayenkar; Editing by Matt Driskill)
Firstpost encourages open discussion and debate, but please adhere to the rules below, before posting. Comments that are found to be in violation of any one or more of the guidelines will be automatically deleted:
Personal attacks/name calling will not be tolerated. This applies to comments directed at the author, other commenters and other politicians/public figures
Please do not post comments that target a specific community, caste, nationality or religion.
While you do not have to use your real name, any commenters using any Firstpost writer's name will be deleted, and the commenter banned from participating in any future discussions.
Comments will be moderated for abusive and offensive language.